Álvaro Torres-Martos , Augusto Anguita-Ruiz , Mireia Bustos-Aibar , Alberto Ramírez-Mena , María Arteaga , Gloria Bueno , Rosaura Leis , Concepción M. Aguilera , Rafael Alcalá , Jesús Alcalá-Fdez
{"title":"多组学和可扩展人工智能为胰岛素抵抗的早期诊断提供决策支持:儿科人群纵向研究","authors":"Álvaro Torres-Martos , Augusto Anguita-Ruiz , Mireia Bustos-Aibar , Alberto Ramírez-Mena , María Arteaga , Gloria Bueno , Rosaura Leis , Concepción M. Aguilera , Rafael Alcalá , Jesús Alcalá-Fdez","doi":"10.1016/j.artmed.2024.102962","DOIUrl":null,"url":null,"abstract":"<div><p>Pediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as <em>HDAC4</em>, <em>PTPRN2</em>, <em>MATN2</em>, <em>RASGRF1</em> and <em>EBF1</em>. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems.</p></div>","PeriodicalId":55458,"journal":{"name":"Artificial Intelligence in Medicine","volume":"156 ","pages":"Article 102962"},"PeriodicalIF":6.1000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0933365724002045/pdfft?md5=8524adfb2927cd0dbcacbe5577c03b65&pid=1-s2.0-S0933365724002045-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study\",\"authors\":\"Álvaro Torres-Martos , Augusto Anguita-Ruiz , Mireia Bustos-Aibar , Alberto Ramírez-Mena , María Arteaga , Gloria Bueno , Rosaura Leis , Concepción M. Aguilera , Rafael Alcalá , Jesús Alcalá-Fdez\",\"doi\":\"10.1016/j.artmed.2024.102962\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Pediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as <em>HDAC4</em>, <em>PTPRN2</em>, <em>MATN2</em>, <em>RASGRF1</em> and <em>EBF1</em>. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems.</p></div>\",\"PeriodicalId\":55458,\"journal\":{\"name\":\"Artificial Intelligence in Medicine\",\"volume\":\"156 \",\"pages\":\"Article 102962\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0933365724002045/pdfft?md5=8524adfb2927cd0dbcacbe5577c03b65&pid=1-s2.0-S0933365724002045-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Artificial Intelligence in Medicine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0933365724002045\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial Intelligence in Medicine","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0933365724002045","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0
摘要
小儿肥胖会大大增加日后发生心血管代谢变化的风险,而胰岛素抵抗是将肥胖与心血管风险增加联系起来的基石。有人指出,青春期是一个关键阶段,过了青春期,肥胖引起的胰岛素抵抗就更难恢复。因此,及时预测小儿肥胖症的胰岛素抵抗对于降低其相关并发症的风险至关重要。要为生命早期阶段胰岛素抵抗这种复杂的健康结果构建有效、稳健的预测系统,就必须采用纵向设计来进行更多的因果推断,并整合导致胰岛素抵抗发生的各种因素。在这项工作中,我们提出了一种基于人工智能的可扩展决策支持管道,用于在 90 名儿童的纵向队列中对胰岛素抵抗进行早期诊断。为此,我们利用了青春期前阶段的多组学(基因组学和表观基因组学)和临床数据。根据机器学习的良好实践,我们考虑了不同的数据层组合、预处理技术(缺失值、特征选择、类不平衡等)、算法和训练程序。还为专家提供了 "SHapley Additive exPlanations",以便他们了解系统的决策机制以及特征对每个自动决策的影响,这在像本项目这样的高风险领域是一个至关重要的问题,因为系统的决策可能会影响到人们的生命。该系统显示了相关的预测能力(AUC 和 G 均值均为 0.92)。在全局和局部层面的深入探索揭示了我们人群中胰岛素抵抗的潜在生物标志物,其中既有经典标志物,如体重指数 z 值或瘦素/脂联素比率,也有新标志物,如相关基因的甲基化模式,如 HDAC4、PTPRN2、MATN2、RASGRF1 和 EBF1。我们的研究结果凸显了在构建决策支持系统时整合多组学数据和遵循易用人工智能趋势的重要性。
Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study
Pediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as HDAC4, PTPRN2, MATN2, RASGRF1 and EBF1. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems.
期刊介绍:
Artificial Intelligence in Medicine publishes original articles from a wide variety of interdisciplinary perspectives concerning the theory and practice of artificial intelligence (AI) in medicine, medically-oriented human biology, and health care.
Artificial intelligence in medicine may be characterized as the scientific discipline pertaining to research studies, projects, and applications that aim at supporting decision-based medical tasks through knowledge- and/or data-intensive computer-based solutions that ultimately support and improve the performance of a human care provider.